Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Repare Therapeutics has raised $101.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2021.
Repare Therapeutics's investors include Business Development Bank of Canada, Redmile Group, OrbiMed, Versant Ventures, Fonds de solidarité FTQ.
Repare Therapeutics is headquartered in Saint Laurent, Canada.
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Repare Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Repare Therapeutics — Funding & Investors." VCBacked, October 27, 2021, https://www.vcbacked.co/company/repare-therapeutics. Accessed September 29, 2026.
VCBacked. (2021). Repare Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/repare-therapeutics
{{cite web |title=Repare Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/repare-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated